“Recent funding initiatives offered by the state of Texas and by other prestigious organizations,” said Lynda Sutton, President and Cofounder of Cato Research, “are setting the foundations for Texas to emerge as a major biotech hub. We have witnessed this directly through our existing and increasing number of new sponsors who are establishing life science operations within the state. We see a major need and advantage for CATO to offer its regulatory and clinical services to local organizations through the support of a specialized, local team. Cato Research is committed to growing a significant presence for this purpose. In addition, the unique opportunity for Cato BioVentures to support the growth and success of products and technologies being developed within the region has given us added impetus to build a meaningful and functional representation. We are excited that CATO is a part of the biotech scene in Texas and is in a position to make a significant contribution to bringing new and innovative products that will result in improved outcomes and quality of life for cancer patients as well as for those with other major diseases. CATO has been involved in many cutting edge developments in its 25-year history, and we anticipate that collaborations and alliances within Texas will result in many more.”
About Cato Research
Founded in 1988 by Dr. Allen Cato and Lynda Sutton and headquartered near Research Triangle Park, North Carolina, Cato Research is a full-service contract research and development organization providing strategic and tactical support for clients in the pharmaceutical, biotechnology, and medical device industries. Serv
Copyright©2012 Vocus, Inc.
All rights reserved